Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AT-101 in advanced adrenocortical carcinoma
NCT00848016Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 2009
- Primary completion
- Mar 2012
- Countries
- 1
01
Overview
A Phase 2 trial of r-(-)-gossypol acetic acid in adrenocortical carcinoma (ACC), sponsored by National Cancer Institute. Started Feb 2009; status: completed.
02
Drugs
r-(-)-gossypol acetic acid
03
Conditions
adrenocortical carcinoma (ACC)
Beyond the preview
Go deeper on NCT00848016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00848016.